Kobayashi Pharmaceutical Co., Ltd. (KBYPF)
USD 37.43
(6.82%)
USD 37.43
(6.82%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 25.78 Billion JPY | -3.33% |
| 2022 | 26.66 Billion JPY | 2.32% |
| 2021 | 26.06 Billion JPY | 0.47% |
| 2020 | 25.94 Billion JPY | -1.56% |
| 2019 | 26.35 Billion JPY | 0.25% |
| 2018 | 26.28 Billion JPY | 14.67% |
| 2017 | 22.92 Billion JPY | 21.24% |
| 2016 | 18.9 Billion JPY | 3.55% |
| 2015 | 18.26 Billion JPY | 1.91% |
| 2014 | 17.91 Billion JPY | -1.13% |
| 2013 | 18.12 Billion JPY | 7.21% |
| 2012 | 16.9 Billion JPY | -37.46% |
| 2011 | 27.02 Billion JPY | 5.77% |
| 2010 | 25.55 Billion JPY | 7.59% |
| 2009 | 23.75 Billion JPY | 8.54% |
| 2008 | 21.88 Billion JPY | -6.3% |
| 2007 | 23.35 Billion JPY | -35.43% |
| 2006 | 36.16 Billion JPY | 114.27% |
| 2005 | 16.87 Billion JPY | -45.48% |
| 2004 | 30.96 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 5.02 Billion JPY | -21.35% |
| 2024 Q2 | 4.44 Billion JPY | -11.63% |
| 2023 Q2 | 5.34 Billion JPY | 5.61% |
| 2023 FY | 25.78 Billion JPY | -3.33% |
| 2023 Q3 | 8.98 Billion JPY | 68.03% |
| 2023 Q4 | 6.39 Billion JPY | -28.82% |
| 2023 Q1 | 5.06 Billion JPY | -36.1% |
| 2022 FY | 26.66 Billion JPY | 2.32% |
| 2022 Q2 | 5.02 Billion JPY | 3.67% |
| 2022 Q1 | 4.84 Billion JPY | -27.02% |
| 2022 Q4 | 7.92 Billion JPY | -10.82% |
| 2022 Q3 | 8.88 Billion JPY | 76.81% |
| 2021 FY | 26.06 Billion JPY | 0.47% |
| 2021 Q4 | 6.63 Billion JPY | -27.73% |
| 2021 Q1 | 4.68 Billion JPY | -27.05% |
| 2021 Q2 | 5.55 Billion JPY | 18.38% |
| 2021 Q3 | 9.18 Billion JPY | 65.48% |
| 2020 FY | 25.94 Billion JPY | -1.56% |
| 2020 Q4 | 6.42 Billion JPY | -30.84% |
| 2020 Q3 | 9.29 Billion JPY | 73.9% |
| 2020 Q2 | 5.34 Billion JPY | 9.64% |
| 2020 Q1 | 4.87 Billion JPY | -19.54% |
| 2019 FY | 26.35 Billion JPY | 0.25% |
| 2019 Q4 | 6.05 Billion JPY | -31.73% |
| 2019 Q3 | 8.87 Billion JPY | 44.69% |
| 2019 Q2 | 6.13 Billion JPY | 16.02% |
| 2019 Q1 | 5.28 Billion JPY | -21.39% |
| 2018 Q1 | 5.56 Billion JPY | -3.62% |
| 2018 Q2 | 6.03 Billion JPY | 8.41% |
| 2018 FY | 26.28 Billion JPY | 14.67% |
| 2018 Q4 | 6.72 Billion JPY | -15.51% |
| 2018 Q3 | 7.96 Billion JPY | 31.91% |
| 2017 Q4 | 5.77 Billion JPY | -14.88% |
| 2017 FY | 22.92 Billion JPY | 21.24% |
| 2017 Q1 | 4.95 Billion JPY | 0.0% |
| 2017 Q2 | 5.4 Billion JPY | 9.02% |
| 2017 Q3 | 6.78 Billion JPY | 25.55% |
| 2016 FY | 18.9 Billion JPY | 3.55% |
| 2016 Q2 | 7.29 Billion JPY | 360.5% |
| 2016 Q3 | 4.56 Billion JPY | -37.5% |
| 2016 Q1 | 1.58 Billion JPY | -78.25% |
| 2015 FY | 18.26 Billion JPY | 1.91% |
| 2015 Q1 | 2.96 Billion JPY | -57.57% |
| 2015 Q4 | 7.28 Billion JPY | 47.71% |
| 2015 Q2 | 4.45 Billion JPY | 50.08% |
| 2015 Q3 | 4.93 Billion JPY | 10.8% |
| 2014 Q4 | 6.99 Billion JPY | 50.98% |
| 2014 Q2 | 3.32 Billion JPY | 8.8% |
| 2014 FY | 17.91 Billion JPY | -1.13% |
| 2014 Q3 | 4.63 Billion JPY | 39.19% |
| 2014 Q1 | 3.05 Billion JPY | -52.52% |
| 2013 Q3 | 4.68 Billion JPY | 18.69% |
| 2013 Q4 | 6.44 Billion JPY | 37.63% |
| 2013 Q2 | 3.94 Billion JPY | 72.33% |
| 2013 Q1 | 2.28 Billion JPY | -67.92% |
| 2013 FY | 18.12 Billion JPY | 7.21% |
| 2012 Q1 | 9.8 Billion JPY | 57.24% |
| 2012 Q2 | 3.8 Billion JPY | -61.18% |
| 2012 Q4 | 7.13 Billion JPY | 41.26% |
| 2012 Q3 | 5.04 Billion JPY | 32.66% |
| 2012 FY | 16.9 Billion JPY | -37.46% |
| 2011 Q2 | 5.44 Billion JPY | -36.51% |
| 2011 Q4 | 6.23 Billion JPY | 15.38% |
| 2011 Q3 | 5.4 Billion JPY | -0.81% |
| 2011 FY | 27.02 Billion JPY | 5.77% |
| 2011 Q1 | 8.58 Billion JPY | 33.33% |
| 2010 Q1 | 7.73 Billion JPY | 18.96% |
| 2010 Q2 | 4.7 Billion JPY | -39.15% |
| 2010 Q3 | 5.82 Billion JPY | 23.87% |
| 2010 FY | 25.55 Billion JPY | 7.59% |
| 2010 Q4 | 6.43 Billion JPY | 10.45% |
| 2009 Q1 | 7.64 Billion JPY | 25.69% |
| 2009 Q3 | 4.88 Billion JPY | -22.82% |
| 2009 Q4 | 6.49 Billion JPY | 32.99% |
| 2009 FY | 23.75 Billion JPY | 8.54% |
| 2009 Q2 | 6.33 Billion JPY | -17.15% |
| 2008 Q4 | 6.08 Billion JPY | 36.65% |
| 2008 FY | 21.88 Billion JPY | -6.3% |
| 2008 Q3 | 4.45 Billion JPY | 0.0% |
| 2007 FY | 23.35 Billion JPY | -35.43% |
| 2006 FY | 36.16 Billion JPY | 114.27% |
| 2005 FY | 16.87 Billion JPY | -45.48% |
| 2004 FY | 30.96 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Science to Consumers, Inc. | - USD | -Infinity% |
| Bemax Inc. | -77.48 Thousand USD | 33269338.214% |
| Bruush Oral Care Inc. | -9.15 Million USD | 281791.372% |
| CCA Industries, Inc. | -192.39 Thousand USD | 13399755.913% |
| DSwiss, Inc. | -51.52 Thousand USD | 50038919.876% |
| EOS, Inc. | -772.6 Thousand USD | 3336846.013% |
| Greyson International, Inc. | -75.9 Thousand USD | 33963607.015% |
| Happy Town Holdings Inc. | - USD | -Infinity% |
| Horrison Resources Inc. | 120 Thousand USD | -21483233.333% |
| Infusion Brands International, Inc. | -6.67 Million USD | 386290.499% |
| Mandom Corporation | 13.35 Million USD | -192968.887% |
| Naples Soap Company Inc. | - USD | -Infinity% |
| Emo Capital Corp. | -543.89 Thousand USD | 4739994.171% |
| Oliveda International, Inc. | -1.3 Million USD | 1968700.141% |
| PacificHealth Laboratories, Inc. | -474.21 Thousand USD | 5436418.318% |
| Prosperous Future Holdings Limited | -26.15 Million USD | 98681.316% |
| PURE Bioscience, Inc. | -3.13 Million USD | 823479.112% |
| PayChest, Inc. | - USD | -Infinity% |
| Skinvisible, Inc. | -490.37 Thousand USD | 5257301.122% |
| Sentient Brands Holdings Inc. | -250.85 Thousand USD | 10276789.296% |
| Sunset Capital Assets, Inc. | -249.51 Thousand USD | 10332061.349% |
| The Stephan Co. | -65 Thousand USD | 39661638.462% |
| Turner Valley Oil & Gas, Inc. | -145.83 Thousand USD | 17677248.617% |
| Winning Brands Corporation | -267.94 Thousand USD | 9621333.892% |
| Warpaint London PLC | 23.55 Million USD | -109323.763% |
| Zoono Group Limited | -2.29 Million USD | 1122549.237% |
| Zurvita Holdings, Inc. | -2.79 Million USD | 923275.207% |